Friday, January 2, 2026 1/2/2026

Cell Type Specific Transcriptional Cascades in Inner Ear Development

Award Number: U01DC013817
ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/01/2015
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Cell Type Specific Transcriptional Cascades in Inner Ear Development - Disabling age-related hearing loss (ARHL) afflicts greater than 50% of the population over the age of 70. The progressive loss of sensory hair cells (HCs) of the cochlea, primarily the outer HCs (OHCs), is either the cause or the final common pathology of most forms of ARHL. However, the molecular basis of ARHL is unknown, impeding development of targeted interventions. Furthermore, attempts to reprogram progenitor cells towards cochlear HC fates result primarily in immature HC-like cells, similar to vestibular HCs. For these reasons, the study of the molecular pathways underlying OHC differentiation and survival is critical. Transcription factors (TFs) are key regulators of gene expression. When associated with disease, identifying the upstream regulators and downstream targets of a TF is an effective route to determine additional key players in the same process. In this competitive renewal we build upon our previous success, identifying critical roles for the RFX and IKZF2 TFs in OHC differentiation, function and survival, and follow up with two specific aims designed to elucidate their molecular mechanism within the HC/OHC genetic programs: Group 1 RFX TFs (RFX1/2/3), are master regulators of ciliogenesis. However, while OHCs lacking Rfx1/3 die within 12 hours from the onset of hearing, they have normal bundle development. RFX2 is transiently expressed in the developing HCs, possibly preventing a ciliogenesis defect with loss of Rfx1/3. We therefore hypothesize that group 1 RFX TFs have a dual role in HC development, with an early role in hair bundle formation, and later role in terminal differentiation and survival. Specific Aim 1: To identify the mechanisms by which RFX TFs support embryonic as well as early post-natal cochlear hair cell differentiation. IKZF2 is a key regulator of OHC gene expression, precisely regulated to express only in OHCs starting from P4. We hypothesize that: (1) deletion of IKZF2 target genes will reveal genes essential for OHC function and survival; (2) IKZF2 is required for maintenance of mature OHCs; and (3) Ikzf2 expression is regulated by a master-regulator of OHC maturation. Specific Aim 2: To identify the mechanism by which IKZF2 leads to OHC differentiation, to determine its role in mature OHCs, and to identify its upstream regulatory network. To accomplish these aims we combine novel protocols for OHC-specific multi-omic analyses with state- of-the-art bioinformatics, and characterization of novel mouse models to validate the roles of candidate genes in hearing. Successful completion of these aims will: (1) impact our understanding of OHC differentiation and survival; (2) functionally characterize the roles of key RFX and IKZF2 target genes in hearing; (3) result in transcriptomic and epigenetic maps of differentiating and mature OHCs which will be applied to inform studies for HC regeneration/identifying candidate genes for ARHL; and (4) generate numerous mouse models for RFX and IKZF2 target genes, which will be readily available to the scientific community. Additionally, all of the data generated as part of this proposal will be shared via the gEAR (umgear.org).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	000	10	11/17/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $490,911 )
2025	2025	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	000	10	11/26/2024	NON-COMPETING CONTINUATION	$490,911
														Subtotal = $490,911

Issue Date FY: 2024 ( Subtotal = $550,739 )
2024	2024	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	001	9	5/7/2024	NON-COMPETING CONTINUATION	$55,073
2024	2024	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	000	9	12/1/2023	NON-COMPETING CONTINUATION	$495,666
														Subtotal = $550,739

Issue Date FY: 2023 ( Subtotal = $574,145 )
2023	2023	UNIVERSITY OF MARYLAND	220 ARCH ST RM 02148	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	003	8	4/14/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF MARYLAND	220 ARCH ST RM 02148	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	000	8	11/30/2022	NON-COMPETING CONTINUATION	$516,731
2023	2023	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	004	8	5/3/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF MARYLAND	220 ARCH ST RM 02148	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	002	8	2/28/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF MARYLAND	220 ARCH ST RM 02148	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	001	8	1/12/2023	NON-COMPETING CONTINUATION	$57,414
														Subtotal = $574,145

Grand Total All Awards = $1,615,795

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cell Type Specific Transcriptional Cascades in Inner Ear Development

Award Number: U01DC013817

ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/01/2015

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer